News & Features

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Data review offers new insights into Alemtuzumab

June 15, 2017

Researchers say this new information will help contribute to the effective management of people with MS.
Learn more

Study probes MS patients’ treatment beliefs, priorities

June 14, 2017

Researchers seek participants for a survey to explore peoples’ experience with medicine for MS, and the attitudes of prescribing clinicians.
Learn more

Multiple Sclerosis Coalition seeks participants for mental health care survey

June 08, 2017

The Multiple Sclerosis Coalition is seeking participants to take a brief, anonymous survey about access to mental health care.
Learn more

Acne medication possible new MS treatment

June 07, 2017

A Canadian clinical trial shows that a common acne medication can slow the progress of relapsing-remitting multiple sclerosis.
Learn more

In MS, problems reading social cues may be tied to brain changes

June 06, 2017

A new study suggests that for people with multiple sclerosis, an impaired ability to understand how others feel and think may be linked to subtle brain changes.
Learn more

FDA approves myBETAapp and Betaconnect Navigator

June 02, 2017

The FDA approved a supplemental Biologics License Application for Bayer’s myBETAapp and the Betaconnect Navigator.
Learn more

Brain neuron density may be better disease progression indicator

May 12, 2017

A new study suggests demyelination may not be as good an indicator of disease progression in multiple sclerosis as previously thought.
Learn more

Augusta University seeks participants in MS survey

May 11, 2017

Augusta University researchers seek to learn more about how patient health has been affected by multiple sclerosis, and what information people living with MS may be lacking.
Learn more

Firm seeks participants for living with MS research study

May 04, 2017

Schlesinger Associates is seeking participants for a research study. The researchers are seeking thoughts and opinions from those living with MS about their experience with treatments and what kinds of unmet needs that they may have.
Learn more

Data review offers new insights into Alemtuzumab

June 15, 2017

Researchers say this new information will help contribute to the effective management of people with MS.
Learn more

Study probes MS patients’ treatment beliefs, priorities

June 14, 2017

Researchers seek participants for a survey to explore peoples’ experience with medicine for MS, and the attitudes of prescribing clinicians.
Learn more

Multiple Sclerosis Coalition seeks participants for mental health care survey

June 08, 2017

The Multiple Sclerosis Coalition is seeking participants to take a brief, anonymous survey about access to mental health care.
Learn more

Acne medication possible new MS treatment

June 07, 2017

A Canadian clinical trial shows that a common acne medication can slow the progress of relapsing-remitting multiple sclerosis.
Learn more

In MS, problems reading social cues may be tied to brain changes

June 06, 2017

A new study suggests that for people with multiple sclerosis, an impaired ability to understand how others feel and think may be linked to subtle brain changes.
Learn more

FDA approves myBETAapp and Betaconnect Navigator

June 02, 2017

The FDA approved a supplemental Biologics License Application for Bayer’s myBETAapp and the Betaconnect Navigator.
Learn more

Brain neuron density may be better disease progression indicator

May 12, 2017

A new study suggests demyelination may not be as good an indicator of disease progression in multiple sclerosis as previously thought.
Learn more

Augusta University seeks participants in MS survey

May 11, 2017

Augusta University researchers seek to learn more about how patient health has been affected by multiple sclerosis, and what information people living with MS may be lacking.
Learn more

Firm seeks participants for living with MS research study

May 04, 2017

Schlesinger Associates is seeking participants for a research study. The researchers are seeking thoughts and opinions from those living with MS about their experience with treatments and what kinds of unmet needs that they may have.
Learn more

Misbehaving mitochondria may play MS role

May 03, 2017

Researchers have discovered a new cellular mechanism – an underlying defect in brain cells – that may cause the multiple sclerosis, and a potential hallmark that may be a target for future treatment of the disease.
Learn more

Phase 1 study suggests possible new treatment for MS

April 26, 2017

The results from a phase 1 study investigating the relationship between MS and the Epstein-Barr virus may show promise of a new type of treatment for progressive multiple sclerosis.
Learn more

Study: MS begins to affect patients sooner than expected

April 21, 2017

People with multiple sclerosis can show signs of something wrong five years before the onset of disease, according to a new analysis of health records from people with the condition
Learn more

MS Focus programs support Spasticity Week

April 10, 2017

MS Focus: the Multiple Sclerosis Foundation will be holding a teleconference and a patient event in support of Spasticity Awareness Week. This year the event will last April 17-21.
Learn more

Researchers target lymph nodes for possible MS treatment

April 04, 2017

In a new study, researchers have developed an experimental treatment that tames the wayward immune system in rodents, returning movement to paralyzed mice. The approach may someday combat multiple sclerosis.
Learn more

Researchers: MicroRNA could hold key to remyelination

March 30, 2017

Scientists partially reinsulated ravaged nerves in mouse models of MS and restored limb mobility by treating the animals with a small non-coding RNA called a microRNA.
Learn more

FDA approves ocrelizumab

March 29, 2017

The U.S. Food and Drug Administration approved Ocrevus (ocrelizumab), made by Genentech, to treat adult patients with relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
Learn more

Researchers find gene interaction linked with MS risk

March 28, 2017

According to a new study, a person carrying variants of two particular genes could be almost three times more likely to develop multiple sclerosis.
Learn more

Scientists find possible MS, protein link

March 24, 2017

Researchers discovered an entirely new cellular mechanism that may to be linked to multiple sclerosis, and a potential hallmark that may be a target for future treatment.
Learn more


Show More News